Adaption and Application of the Four Phase Trials to Traditional Chinese Medicines

Por Di, M. Y., Tang, J. L.
Publicado em 2013

How effective is nicotine replacement therapy in helping people to stop smoking?

Por Tang, J. L., Law, M., Wald, N.
Publicado em 1994

Adjusted impact factors for comparisons between disciplines

Por Tang, J. L., Wong, T. W., Liu, J. L.
Publicado em 1999

Extracellular proteases from Xanthomonas campestris pv. campestris, the black rot pathogen.

Por Dow, J M, Clarke, B R, Milligan, D E, Tang, J L, Daniels, M J
Publicado em 1990

Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts.

Por Tang, J. L., Morris, J. K., Wald, N. J., Hole, D., Shipley, M., Tunstall-Pedoe, H.
Publicado em 1995

Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects

Por Tang, J L, Armitage, J M, Lancaster, T, Silagy, C A, Fowler, G H, Neil, H A W
Publicado em 1998

Endothelin-1 Receptor Blockade and its Effect on Chronic Rejection

Por Tang, J.L., Aitouche, A, Subbotin, V., Salam, A., Sun, H., Gandhi, C., Valdivia, L.A., Fung, J.J., Starzl, T.E., Rao, A.S.
Publicado em 1999

Ideal cardiovascular health status and its association with socioeconomic factors in Chinese adults in Shandong, China

Por Ren, J., Guo, X. L., LU, Z. L., Zhang, J. Y., Tang, J. L., Chen, X., Gao, C. C., Xu, C. X., Xu, A. Q.
Publicado no BMC Public Health (2016)

Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia

Por Hou, H-A, Kuo, Y-Y, Liu, C-Y, Lee, M C, Tang, J-L, Chen, C-Y, Chou, W-C, Huang, C-F, Lee, F-Y, Liu, M-C, Yao, M, Tien, H-F
Publicado em 2011

High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes

Por Cheng, C-L, Hou, H-A, Jhuang, J-Y, Lin, C-W, Chen, C-Y, Tang, J-L, Chou, W-C, Tseng, M-H, Yao, M, Huang, S-Y, Ko, B-S, Hsu, S-C, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado em 2011

Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia

Por Hou, H-A, Lu, J-W, Lin, T-Y, Tsai, C-H, Chou, W-C, Lin, C-C, Kuo, Y-Y, Liu, C-Y, Tseng, M-H, Chiang, Y-C, Peng, Y-L, Tang, J-L, Gong, Z, Lin, L-I, Tien, H-F
Publicado no Blood Cancer J (2017)

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

Por Chen, T-C, Hou, H-A, Chou, W-C, Tang, J-L, Kuo, Y-Y, Chen, C-Y, Tseng, M-H, Huang, C-F, Lai, Y-J, Chiang, Y-C, Lee, F-Y, Liu, M-C, Liu, C-W, Liu, C-Y, Yao, M, Huang, S-Y, Ko, B-S, Hsu, S-C, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado em 2014

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

Por Hou, H-A, Chou, W-C, Kuo, Y-Y, Liu, C-Y, Lin, L-I, Tseng, M-H, Chiang, Y-C, Liu, M-C, Liu, C-W, Tang, J-L, Yao, M, Li, C-C, Huang, S-Y, Ko, B-S, Hsu, S-C, Chen, C-Y, Lin, C-T, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado no Blood Cancer J (2015)